Elsevier Inc.

SHERPA: Unknown

People

  1. Kemeny
    Kemeny
  2. Kris
    Kris
  3. Bajorin
    Bajorin
  4. Bosl
    Bosl
  5. Motzer
    Motzer
  6. Herr
    Herr

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Gastrointestinal Oncology Service (4)
  4. Thoracic Oncology (4)
  5. Genitourinary Oncology Service (3)
  6. Survivorship Research (3)
  7. Center for Hematologic Malignancies (1)
  8. Executive Committee, Center for Hematologic Malignancies (1)
  9. Hematologic Malignancies, Division of (1)
  10. Lymphoma (1)
Search Within
  1. "Seminars in Oncology"
  2. "Solid Tumor Oncology Division"
  3. "1992"
Formats
  1. Journal Article (8)
  2. Conference Paper (3)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Gastrointestinal Oncology Service (4)
  4. Thoracic Oncology (4)
  5. Genitourinary Oncology Service (3)
  6. Survivorship Research (3)

More Groups

People
  1. Mark Kris (4)
  2. Nancy Kemeny (4)
  3. Dean Bajorin (3)
  4. George Bosl (3)
  5. Robert Motzer (3)
  6. Anas Younes (1)

More People

Years
  1. 1992 (11)
Publications
  1. Seminars in Oncology (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • "Poor risk" germ cell tumors: Current progress and future directions
    Journal Article

    Motzer, R. J.; Bajorin, D. F.; Bosl, G. J.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Phase II trials of ondansetron with high-dose cisplatin
    Conference Paper

    Kris, M. G.
    Elsevier Inc. (1992)

    Fulltext@MSK | Save
  • Ondansetron: A new concept in the management of emesis: A panel discussion. Part 1
    Journal Article

    Gralla, R. J.; Tyers, M. B.; Pritchard, J. F.; Kris, M. G.; Grunberg, S. M.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Rationale for combination antiemetic therapy and strategies for the use of ondansetron in combinations
    Conference Paper

    Kris, M. G.
    Elsevier Inc. (1992)

    Fulltext@MSK | Save
  • Ondansetron: A new concept in the management of emesis: A panel discussion. Part 2
    Journal Article

    Gralla, R. J.; Hesketh, P. J.; Fraschini, G.; Hainsworth, J. D.; Finn, A. L.; Gandara, D. R.; Kris, M. G.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: The Memorial Sloan-Kettering experience
    Conference Paper

    Kemeny, N.; Younes, A.
    Elsevier Inc. (1992)

    Fulltext@MSK | Save
  • Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: A review
    Journal Article

    Martin, D. S.; Kemeny, N. E.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Review of regional therapy of liver metastases in colorectal cancer
    Journal Article

    Kemeny, N.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Motzer, R. J.; Bajorin, D. F.; Vlamis, V.; Weisen, S.; Bosl, G. J.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors
    Journal Article

    Bajorin, D. F.; Herr, H.; Motzer, R. J.; Bosl, G. J.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save